Use of an Infotainment System in MRI in Patients Suffering From Unexpected Anxiety.
NCT ID: NCT07246746
Last Updated: 2026-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2026-01-12
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Nevertheless, these routine examinations remain a source of apprehension and anxiety for some people.
The objective of this study is to compare two methods of care, enabling anxious individuals to complete their MRI examination and obtain images of sufficient quality for the radiologist to read and interpret.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an MRI-compatible Vital Signs Sensor System
NCT03384849
Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation
NCT01006746
Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers
NCT05771909
Anxiety Associated With the Use of the Electrocardiogram Function in Smart Watches
NCT06131463
When Distance is an Act of Love: Exploring the Use of Video Diaries for Family Members of Intensive Care Patients
NCT04870450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Innovision©
Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire
Assessment of patient anxiety
Anxiety support procedure according to randomization: Innovision© or Hypnosis
Hypnosis or Innovision device
Hypnosis control
Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire
Assessment of patient anxiety
Anxiety support procedure according to randomization: Innovision© or Hypnosis
Hypnosis or Innovision device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire
Assessment of patient anxiety
Anxiety support procedure according to randomization: Innovision© or Hypnosis
Hypnosis or Innovision device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals over the age of 18
* Hospitalized or ambulatory individuals who are able-bodied and scheduled to undergo a brain MRI scan on the 1.5T A MRI machine at the Dijon University Hospital.
* Individuals reporting anxiety about brain MRI for the first time upon admission by the radiology technician.
Exclusion Criteria
* Persons subject to legal protection measures (guardianship, trusteeship)
* Persons subject to judicial protection measures
* Women who know they are pregnant
* Adults who are incapable or unable to give their consent
* Persons with contraindications to MRI
* Persons who have already undergone an MRI accompanied by hypnosis
* Persons who do not speak French
* Persons who cannot read French
* Persons with cognitive disorders
* Persons who have taken sedatives before the examination
* Persons who regularly take anxiolytic medication and have increased their usual dose before the examination
* Persons who have already participated in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIGNOT AOIparaM 2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.